The management of pregnancy complicated by heart disease

Ullery, John C.

doi:10.1016/0002-9378(54)90107-6

Cited by 20 publications

(3 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, MacRae (1953) reported a series of 228 cases and Macleod (1954) a series of 100 cases, each with no maternal deaths. Other series published within the past ten years quote maternal mortality rates varying from 4.1 per cent (Douglas and Hoopes, 1951) to 2.6 per cent (Ullery, 1954). Browne and Browne (1955) are of the opinion that the mortality rate depends on the adequacy of antenatal care, and state that the rate varies from 3 to 70 per cent.…”

Section: Maternal Mortalitymentioning

confidence: 99%

Pregenency Associated With Cardiac Disease

Sutherland

Bruce

1962

BJOG

View full text Add to dashboard Cite

Section: Maternal Mortalitymentioning

confidence: 99%

Pregenency Associated With Cardiac Disease

Sutherland

Bruce

1962

BJOG

View full text Add to dashboard Cite

“…It is surprising, therefore, that the reported incidence of thromboembolic disease in pregnancy is small, ranging from 0-018 (Ullery, 1954) to 0.29 (Rochat, 1939) per 100 deliveries. However, despite this, thromboembolic disease is a serious complication of pregnancy, carrying with it a raised maternal and fetal mortality rate.…”

mentioning

confidence: 99%

Management and Treatment of 34 Cases of Antepartum Thromboembolism

Duncan

Coyle

Walker

1971

BJOG

View full text Add to dashboard Cite

Summary Thirty‐four patients with antenatal venous thromboembolism seen in Dundee Royal Infirmary between 1960 and 1969 are reviewed in an attempt to define the patient at risk. No pregnant woman is immune but older parous patients with a history of venous trouble and subjected to rest in bed are likely to develop the condition. The diagnosis of deep venous thrombosis and the medical management of patients with antenatal deep venous thrombosis are discussed. There may be a place for the use of low molecular weight Dextran during labour and in the early puerperium. Although postpartum recurrence of deep venous thrombosis did not occur significantly more frequently in patients who had received stilboestrol to suppress lactation, all the cases of puerperal pulmonary embolism occurred in patients who had received either stilboestrol or hexoestrol. It appears unwise to administer substances which are known to raise blood clotting factors to patients who are already notably susceptible to venous thrombosis. Antepartum and postpartum anticoagulation regimens are suggested.

show abstract

“…The mortality of antepartum thromboembolism has been reported to be about 150,, in untreated patients, but there has been only one death in over 100 reported cases given anticoagulants (Ullery, 1954;Finnerty and McKay, 1962;DeVita et al, 1965;Villasanta, 1965a). Even allowing for possible selection bias, the available evidence would suggest that anticoagulant therapy significantly reduces mortality in antepartum thromboembolism.…”

Section: Maternal Mortality and Morbiditymentioning

confidence: 99%